Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03362086
What this trial is testing

The Osteosarcoma Biobank in Peking University People's Hospital

Who this might be right for
Osteosarcoma
Peking University People's Hospital 180
Early research (Phase 1)Ended earlyNCT05116254
What this trial is testing

Sarcomas and DDR-Inhibition; a Combined Modality Study

Who this might be right for
Soft Tissue Sarcoma Adult
The Netherlands Cancer Institute 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793253
What this trial is testing

Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer

Who this might be right for
Biliary Tract CancersIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Not applicableStudy completedNCT01621295
What this trial is testing

Assessing the Patient Experience in Cancer Care

Who this might be right for
Brain NeoplasmBreast NeoplasmEndocrine Gland Neoplasm+7 more
Mayo Clinic 408
Large-scale testing (Phase 3)Study completedNCT01168791
What this trial is testing

Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Alaunos Therapeutics 447
Testing effectiveness (Phase 2)Study completedNCT00004180
What this trial is testing

Rosiglitazone in Treating Patients With Liposarcoma

Who this might be right for
Sarcoma
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT00256490
What this trial is testing

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

Who this might be right for
Lymphoma, Large-Cell
Eric Turcotte 82
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06041490
What this trial is testing

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsHepatocarcinomaRecurrent Osteosarcoma+1 more
Peking Union Medical College Hospital 88
Not applicableStudy completedNCT03404297
What this trial is testing

Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya

Who this might be right for
Chronic Leg UlcerKaposi SarcomaHIV/AIDS and Infections
Indiana University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT01442662
What this trial is testing

Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine

Who this might be right for
Leiomyosarcoma
UNICANCER 106
Not applicableLooking for participantsNCT07062003
What this trial is testing

Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors

Who this might be right for
Metastatic Malignant Skin NeoplasmMetastatic Malignant Soft Tissue NeoplasmRecurrent Malignant Skin Neoplasm+3 more
Mayo Clinic 60
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Not applicableLooking for participantsNCT02792270
What this trial is testing

Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

Who this might be right for
Tumor Surgery
Massachusetts General Hospital 32
Not applicableEnrolling By InvitationNCT07264296
What this trial is testing

Implant-Related Infections in Patients With Skeletal Sarcomas

Who this might be right for
Implant InfectionSkeletal SarcomaHip Arthritis+2 more
Vastra Gotaland Region 40
Testing effectiveness (Phase 2)Looking for participantsNCT06534762
What this trial is testing

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Who this might be right for
NSCLCSCLCColorectal Cancer+4 more
Zhejiang Provincial People's Hospital 260
Testing effectiveness (Phase 2)Study completedNCT01913652
What this trial is testing

Ph II Cabazitaxel DD Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
European Organisation for Research and Treatment of Cancer - EORTC 42
Not applicableLooking for participantsNCT07377747
What this trial is testing

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

Who this might be right for
Retroperitoneal Liposarcoma
Australia and New Zealand Sarcoma Association 100
Large-scale testing (Phase 3)Study completedNCT02451943
What this trial is testing

Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 509
Next Page